Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
The UK government has signed a deal with Becton Dickinson & Co. to obtain 65 million injection devices to prepare for a COVID-19 vaccination program. The first shipments of the injection devices have already arrived in the UK, with the full order expected to be delivered by September 2020.
Due to the need to deploy future COVID-19 vaccinations quickly, they are expected to be made available initially in single or multidose vials. This requires the use of separate needles and syringes to draw the vaccine from the vial and administer it to patients.
"BD’s dose-sparing injection devices are engineered to increase the available amount of vaccine by minimizing vaccine waste. These devices can also play an essential role in expanding available vaccine doses during a pandemic. The savings associated with lower vaccine waste are greater than the total cost of dose-sparing injection devices," BD UK&I general manager, Mike Fairbourn told Medtech Insight.
BD is the largest manufacturer of injection devices in the world. In June, the company secured its first deal with the Canadian government to supply 37 million injection devices for COVID-19 vaccines. According to Fairbourn, the company is in discussions with the US and multiple other governments around the world to supply more of the devices.
"The UK selected a device that was able to be produced and delivered in a very rapid timeframe to ensure they are prepared for whenever a vaccine is prepared," said Fairbourn. "We aren’t vaccine manufacturers, so we won’t speculate on timing, but widely published reports show a vaccine is expected late in 2020 or early in 2021."
Fairbourn said the deal is not material to BD from a financial perspective.
Medtech Insight: global medical technology news & analysis
By Ashley Yeo 28 Sep 2020
ABHI’s Phil Brown looks beyond the immediate challenges for UK medtechs on being outside the EU, and to an innovation-friendly...
Medtech Insight: global medical technology news & analysis
By Amanda Maxwell 28 Sep 2020
Detailed talks are still needed between the EU and Switzerland over the future of their mutual recognition agreement. But the...
Medtech Insight: global medical technology news & analysis
The Cumberlege Review of patient safety delivered a damning verdict on the UK’s health system. Its recommendations must be acted on, says a consensus of stakeholders.
Topics Policy & Regulation Medtech
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
In the continually evolving medtech competitive landscape, it is vital to stay up-to-date with key events. With Meddevicetracker, you’ll be able to anticipate upcoming filings, research clinical trial dates and data, and access market size information and expert forecasts, all in one place.
Get a window into what the leading players across the biopharma, medtech, and diagnostics industries are thinking, as well as important insight into what your competitors are doing. Build your strategy with In Vivo.
Looking for more products Product Finder
